Madrigal Pharmaceuticals Inc
LSE:0JXI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Madrigal Pharmaceuticals Inc (0JXI) under the Base Case is USD per share.
Compared with the current market price of 422.98 USD, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 10 months.
Create a free account · No card needed
Fundamental Analysis
What Madrigal Pharmaceuticals Does
Madrigal Pharmaceuticals is a biopharmaceutical company focused on treating metabolic and liver disease. Its main product is a prescription medicine for adults with noncirrhotic steatohepatitis, a serious form of fatty liver disease now often called MASH. The company does not run a broad drug portfolio; it is centered on this one disease area and the therapy built for it.
- Headquarters
- United States of America US
- Employees
- 915
- IPO date
- Feb 6, 2007
Madrigal Pharmaceuticals has no economic moat
Doctors can choose competing treatments, so Madrigal cannot rely on a captive group of patients or a market that only it can serve. Rezdiffra’s patents protect the drug itself, but do not stop other medicines from treating MASH, and the drug does not become more valuable as more people use it.
Read the full moat analysisContinue 0JXI Research
Decided on Madrigal Pharmaceuticals? Get an email when 0JXI reaches the price you’d buy at. Free with an account.
Other Madrigal Pharmaceuticals listings
What is the Intrinsic Value of one 0JXI stock?
The intrinsic value for
Madrigal Pharmaceuticals Inc (0JXI) under the Base Case is USD.
Is 0JXI stock undervalued or overvalued?
Compared with the current market price of 422.98 USD, the stock appears .